Collaboration with Clinics/Physicians
NiaMedic Healthcare & Research Services Ltd. is a data and healthcare company offering innovative, multi-disciplinary, medical consultation, and research services.
NiaMedic provides advanced integration of proprietary Medical Cannabis treatment with conventional medical care.
NiaMedic’s treatment protocols are developed by a team of experts that utilize its comprehensive research platform in collaboration with a network of leading, renowned researchers.
NiaMedic is at the forefront of the highly sought-after Medical Cannabis industry and is looking to partner with leading providers and clinics to provide safer, more effective personalized quality patient care.
We have created unique Medical Cannabis treatment protocols which are based on over a decade of clinical experience and research. Our team specializes in customizing a step by step Medical Cannabis treatment plan for each patient’s individual needs.
Our specialized team of medical professionals will provide comprehensive care and support during the integration of medical cannabis into patients' overall healthcare plan.
What conditions do we treat?
Medical Cannabis is being clinically used in treating numerous Medical conditions & symptoms, including.
Pain - Neuropathic, Orthopedic and Rheumatic
Neurological conditions - Parkinson’s Disease, Epilepsy, Tourette Syndrome, MS, etc.
Rheumatological conditions - RA, Fibromyalgia, Osteoporosis, etc.
Gastrointestinal conditions - Crohn’s, Colitis, IBS, etc.
Pulmonary conditions - COPD, Asthma.
Psychiatric disorders - PTSD, anxiety, depression
Spasticity, tremors, dystonia, etc.
Chemotherapy side effects
Nutritional and eating disorders
NiaMedic’s Treatment Protocols:
Our treatment methods are individually customized and patient focused which include:
Customizing optimal treatment plan based on symptoms and conditions.
Matching products to symptoms and conditions based on chemical analysis.
Utilizing advanced dosage methodologies for optimal and safe results.
Analyzing patient’s medications to reduce drug-on-drug and cannabis-on-drug interactions.
At least one month of supervised titration of the patient’s customized treatment plan.
Monitoring for safety & effectiveness of recommended products.
NiaMedic’s Treatments Highlights:
93.8% of patients reported improvement in their condition, while none reported deterioration.
87.5% reported significant pain reduction, reported pain level was reduced by an average of 7.5 points on a scale of 0-10 (VAS).
Over 50% of the patients stopped using opioids or other analgesics & over 25% reduced their doses.
Over 50% of the patients reported an improvement in their appetite.
A reduction of 17% in the total number of medications used.
Reduction in hospitalization days.
Positive effects on the urinary system and joint pain.
94% of the patients reported no psychoactive sensation-side effects.